earnings
confidence high
sentiment neutral
materiality 0.50
Reaffirms full-year 2025 adjusted EPS guidance of $30.00 and benefit expense ratio of 90.0%
Elevance Health, Inc.
- Reaffirms FY2025 GAAP EPS guidance of ~$24.10, including ~$5.90 net unfavorable items.
- Reaffirms FY2025 adjusted EPS guidance of ~$30.00 per diluted share.
- Reaffirms FY2025 benefit expense ratio guidance of approximately 90.0%.
- Company officers to discuss outlook with investors over next several weeks.